ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,662Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 393

$878K Total Retail Price of All Prescriptions

Rank: 6 out of 393

551 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 551 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

25% of this provider’s 551 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,811 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 792 469 1 2
HYDROCODONE-ACETAMINOPHEN 676 315 S3 2 5
PRAVASTATIN SODIUM 525 361 3 18
AMLODIPINE BESYLATE 459 373 4 4
LOSARTAN POTASSIUM 386 307 5 12
METFORMIN HCL 343 211 6 7
OMEPRAZOLE 311 231 7 6
LEVOTHYROXINE SODIUM 297 210 8 3
FUROSEMIDE 280 148 9 8
SIMVASTATIN 278 196 10 1
GABAPENTIN 274 150 11 15
FAMOTIDINE 268 128 12 70
CARVEDILOL 264 138 13 21
ZOLPIDEM TARTRATE 250 117 14 11
ATORVASTATIN CALCIUM 242 144 15 19
POTASSIUM CHLORIDE 231 141 16 20
ATENOLOL 204 148 17 13
LOVASTATIN 200 168 18 14
CARISOPRODOL 195 35 R 19 45
ISOSORBIDE MONONITRATE ER 189 117 20 67
HYDRALAZINE HCL 174 109 21 64
FENOFIBRATE 144 75 22 43
LYRICA 132 64 23 119
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 83 24 24
LIDODERM 113 105 25 116
LANTUS SOLOSTAR 112 77 26 74
WARFARIN SODIUM 111 46 27 17
NAMENDA 105 104 28 59
FLUTICASONE PROPIONATE 104 38 29 27
OXYCODONE-ACETAMINOPHEN 104 16 S2 29 71
PEN NEEDLE 102 71 31 81
ALENDRONATE SODIUM 99 90 32 16
METOPROLOL TARTRATE 97 79 33 9
MORPHINE SULFATE ER 95 26 S2 34 48
LOVAZA 94 34 35 114
OXYCODONE HCL-ACETAMINOPHEN 94 30 S2 35 54
SPIRONOLACTONE 90 31 37 82
TRAMADOL HCL 87 54 38 30
ALLOPURINOL 87 62 38 26
TAMSULOSIN HCL 85 70 40 25
BYSTOLIC 84 81 41 154
CLOPIDOGREL 83 54 42 33
CITALOPRAM HBR 81 22 43 23
CRESTOR 80 49 44 52
IBUPROFEN 80 29 44 55
CYMBALTA 75 39 46 88
NAPROXEN 72 50 47 85
VESICARE 72 35 47 255
CYCLOBENZAPRINE HCL 71 17 R 49 109
LIPITOR 70 48 50 123
LOSARTAN-HYDROCHLOROTHIAZIDE 69 42 51 31
JANUVIA 69 28 51 87
GLIMEPIRIDE 69 45 51 39
DONEPEZIL HCL 68 68 54 34
TRAZODONE HCL 65 35 55 47
SERTRALINE HCL 64 30 56 28
QUETIAPINE FUMARATE 64 47 56 104
CLONIDINE HCL 63 41 58 50
LACTULOSE 63 21 58 148
PROAIR HFA 62 28 60 68
PREDNISONE 60 42 61 65
GLYBURIDE-METFORMIN HCL 59 32 R 62 125
NOVOLOG FLEXPEN 58 26 63 127
VERAPAMIL ER 57 44 64 86
METOCLOPRAMIDE HCL 57 14 64 141
BACLOFEN 56 33 66 79
PLAVIX 55 30 67 51
VENTOLIN HFA 54 24 68 42
TEMAZEPAM 53 0 69 296
TRIAMTERENE-HCTZ 52 31 70 49
ZETIA 52 40 70 103
NEXIUM 52 0 70 84
CARBIDOPA-LEVODOPA 51 37 73 142
METOPROLOL SUCCINATE 50 47 74 22
NOVOLOG 50 13 74 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.